This article has been cited by other articles in PMC.
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (630K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
These references are in PubMed. This may not be the complete list of references from this article.
Beck RE, Boyes DA. Treatment of 126 cases of advanced ovarian carcinoma with cyclophosphamide. Can Med Assoc J. 1968 Mar 16;98(11):539–541.[PMC free article][PubMed]
Bruckner HW, Ratner LH, Cohen CJ, Wallach R, Kabakow B, Greenspan EM, Holland JF. Combination chemotherapy for ovarian carcinoma with cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) after failure of initial chemotherapy. Cancer Treat Rep. 1978 Jul;62(7):1021–1023.[PubMed]
Bush RS, Allt WE, Beale FA, Bean H, Pringle JF, Sturgeon J. Treatment of epithelial carcinoma of the ovary: operation, irradiation, and chemotherapy. Am J Obstet Gynecol. 1977 Apr 1;127(7):692–704.[PubMed]
Decker DG, Mussey E, Malkasian GD, Jr, Johnson CE. Cyclophosphamide in the treatment of ovarian cancer. Clin Obstet Gynecol. 1968 Jun;11(2):382–400.[PubMed]
DeVita VT, Jr, Wasserman TH, Young RC, Carter SK. Perspectives on research in gynecologic oncology. Cancer. 1976 Jul;38(1 Suppl):509–525.[PubMed]
Johnson CE, Decker DG, Van Herik M, Mussey E, Malkasian GD, Jorgensen EO. Advanced ovarian cancer: therapy with radiation and cyclophosphamide in a random series. Am J Roentgenol Radium Ther Nucl Med. 1972 Jan;114(1):136–141.[PubMed]
Kottmeier HL. Treatment of ovarian cancer with thiotepa. Clin Obstet Gynecol. 1968 Jun;11(2):428–438.[PubMed]
Masterson JG, Nelson JH., Jr The role of chemotherapy in the treatment of gynecologic malignancy. Am J Obstet Gynecol. 1965 Dec 15;93(8):1102–1111.[PubMed]
Parker RT, Parker CH, Wilbanks GD. Cancer of the ovary. Survival studies based upon operative therapy, chemotherapy, and radiotherapy. Am J Obstet Gynecol. 1970 Nov 15;108(6):878–888.[PubMed]
Piver S, Barlow JJ, Chung WS, Lee FT, Vongtama V. Primary treatment of advanced ovarian adenocarcinoma, stages III and IV. Natl Cancer Inst Monogr. 1975 Oct;42:177–182.[PubMed]
Rubin P. Understanding the problem of understaging in ovarian cancer. Semin Oncol. 1975 Sep;2(3):235–242.[PubMed]
Smith JP, Rutledge F. Chemotherapy in the treatment of cancer of the ovary. Am J Obstet Gynecol. 1970 Jul 1;107(5):691–703.[PubMed]
Smith JP, Rutledge F, Wharton JT. Chemotherapy of ovarian cancer. New approaches to treatment. Cancer. 1972 Dec;30(6):1565–1571.[PubMed]
Smith JP, Rutledge FN, Delclos L. Postoperative treatment of early cancer of the ovary: a random trial between postoperative irradiation and chemotherapy. Natl Cancer Inst Monogr. 1975 Oct;42:149–153.[PubMed]
Tobias JS, Griffiths CT. Management of ovarian carcinoma. Current concepts and future prospects. N Engl J Med. 1976 Apr 15;294(16):877–882.[PubMed]
Wampler GL, Mellette SJ, Kuperminc M, Regelson W. Hexamethylmelamine (NSC-13875) in the treatment of advanced cancer. Cancer Chemother Rep. 1972 Aug;56(4):505–514.[PubMed]
Wiltshaw E, Kroner T. Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in advanced adenocarcinoma of the ovary. Cancer Treat Rep. 1976 Jan;60(1):55–60.[PubMed]
Young RC. Chemotherapy of ovarian cancer: past and present. Semin Oncol. 1975 Sep;2(3):267–276.[PubMed]
Young RC, Chabner BA, Hubbard SP, Canellos GP, DeVita VT., Jr Preliminary Results of trials of chemotherapy in advanced ovarian carcinoma. Natl Cancer Inst Monogr. 1975 Oct;42:145–148.[PubMed]
Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press